Treatment with the IL-1R antagonist (IL-1Ra) resulted in the decreased infiltration of immune cells in islets of GK rats (a spontaneous, non-obese model of T2D), that resulted in improvement of insulin secretion and glycaemic control [166]. Here, INS is linked to type 2 diabetes mellitus.